EKEun-Rim Kang

Eun-Rim Kang

*This is an algorithmically generated author record based on publicly available information.

Eun-Rim Kang has a total of 7 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Coinfections with Respiratory Pathogens among COVID-19 Patients in Korea

    by Kyoung Ho Roh, Yu Kyung Kim, Shin-Woo Kim, Eun-Rim Kang, Yong-Jin Yang, Sun-Kyung Jung, Sun-Hwa Lee, Nackmoon Sung

    The detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in upper and lower respiratory specimens and coinfection with other respiratory pathogens in patients with coronavirus disease 2019 (COVID-19) was investigated. Study subjects (N=342) were retrospectively enrolled after being confirmed as SARS-CoV-2 positive, and their nasopharyngeal swab (NPS), oropharyngeal swab (OPS), and sputum specimens were restored for SARS-CoV-2 retesting and respiratory pathogen detection. The majority of the subjects (96.5, N=330) were confirmed as SARS-CoV-2 positive using NPS/OPS specimens. Among the COVID-19 patients (N=342), 7.9 (N=27) and 0.9 (N=3) were coinfected with respiratory viruses and Mycoplasma pneumoniae, respectively, yielding an 8.8 (N=30) overall respiratory pathogen coinfection rate. Of the respiratory virus coinfection cases (N=27), 92.6 (N=25) were coinfected with a single respiratory virus and 7.4 (N=2) with two viruses (metapneumovirus/adenovirus and rhinovirus/bocavirus). No triple coinfections of other respiratory viruses or bacteria with SARS-CoV-2 were detected. Respiratory viruses coinfected in the patients with COVID-19 were as follows: rhinovirus (N=7, 2.1), respiratory syncytial virus A and B (N=6, 1.8), non-SARS-CoV-2 coronaviruses (229E, NL63, and OC43, N=5, 1.5), metapneumovirus (N=4, 1.2), influenza A (N=3, 0.9), adenovirus (N=3, 0.9), and bocavirus (N=1, 0.3). In conclusion, the diagnostic value of utilizing NPS/OPS specimens is excellent, and, as the first report in Korea, coinfection with respiratory pathogens was detected at a rate of 8.8 in patients with COVID-19.


  • Open Access

    Coinfection with Respiratory Pathogens in COVID-19 in Korea

    by Kyoung Ho Roh, Yu Kyung Kim, Shin-Woo Kim, Eun-Rim Kang, Yong-Jin Yang, Sun-Kyung Jung, Sun-Hwa Lee, Nackmoon Sung

    Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in upper and lower respiratory specimens and coinfection with other respiratory pathogens in patients with coronavirus disease 2019 (COVID-19) were investigated. From the study subjects (N = 258) retrospectively enrolled when confirmed as SARS-CoV-2 positive, nasopharyngeal (NPS), oropharyngeal swabs (OPS), and sputum specimens were restored for retesting SARS-CoV-2 and detecting respiratory pathogens. Majority of the study subjects (95.7%, N = 247) were confirmed as SARS-CoV-2 positive using NPS/OPS specimens, suggesting that the upper respiratory specimen is most valuable in detecting SARS-CoV-2. Coinfection rates in COVID-19 patients (N = 258) with respiratory pathogens were 9.7% (N = 25); 8.5% (N = 22) respiratory viruses and 1.2% (N = 3) Mycoplasma pneumoniae , an atypical bacterium. Of the respiratory virus coinfection cases (N = 22), 20 (90.9%) were co-infected with a single respiratory virus and 2 (0.8%) (metapneumovirus/adenovirus and rhinovirus/bocavirus 1/2/3/4) with two viruses. Respiratory viruses in single viral coinfection cases with SARS-CoV-2 were as follows: non-SARS-CoV-2 coronaviruses (229E, NL63, and OC43, N = 5, 1.9%), rhinovirus (N = 4, 1.6%), metapneumovirus (N = 3, 1.2%), influenza A (N = 3, 1.2%), respiratory syncytial virus A and B (N = 3, 1.2%), and adenovirus (N = 2, 0.8%). No mixed coinfections with respiratory viruses and M. pneumonia e were found. In conclusion, the diagnostic value of utilizing NPS/OPS specimen is excellent, and, as the first report in Korea, coinfection with respiratory pathogens were detected at a rate of 9.7% in patients with COVID-19.